Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases.
Shenyang Institute of Computing Technology, CAS and Chinese PLA General Hospital Joint Team conduct series of investigations on Infantile Spasms Syndrome (IESS), also known as West syndrome, discovering a video-based epileptic seizure detection method that effectively enhances the accuracy of infantile spasm identification.
More than 50 million people worldwide live with epilepsy, with approximately half of them being children. For about one-third of these patients, medications do not control their seizures, leaving surgery as the only viable option for seizure relief.
A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients' brains that cause treatment-resistant epilepsy.
The parts of the brain that are needed to remember words, and how these are affected by a common form of epilepsy, have been identified by a team of neurologists and neurosurgeons at UCL.
Brain implants hold immense promise for restoring function in patients with paralysis, epilepsy and other neurological disorders.
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of
our websites
and requested to be notified of additional information.
